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Foot-and-mouth diseasea b s t r a c t
Identifying the drivers of vaccine adoption decisions under varying levels of perceived disease risk and
benefit provides insight into what can limit or enhance vaccination uptake. To address the relationship
of perceived benefit relative to temporal and spatial risk, we surveyed 432 pastoralist households in
northern Tanzania on vaccination for foot-and-mouth disease (FMD). Unlike human health vaccination
decisions where beliefs regarding adverse, personal health effects factor heavily into perceived risk, deci-
sions for animal vaccination focus disproportionately on dynamic risks to animal productivity. We
extended a commonly used stated preference survey methodology, willingness to pay, to elicit responses
for a routine vaccination strategy applied biannually and an emergency strategy applied in reaction to
spatially variable, hypothetical outbreaks. Our results show that households place a higher value on vac-
cination as perceived risk and household capacity to cope with resource constraints increase, but that the
episodic and unpredictable spatial and temporal spread of FMD contributes to increased levels of uncer-
tainty regarding the benefit of vaccination. In addition, concerns regarding the performance of the vac-
cine underlie decisions for both routine and emergency vaccination, indicating a need for within
community messaging and documentation of the household and population level benefits of FMD
vaccination.
 2018 The Authors. Published by Elsevier Ltd. This is an openaccess article under the CCBY license (http://
creativecommons.org/licenses/by/4.0/).1. Introduction immunity is lost, and vaccination benefits may only extend toUncertainty surrounding health decisions stems from unknown
gains in personal wellbeing relative to the perceived costs of
undertaking the intervention. This is specifically applicable to vac-
cination decisions. For example, the decision to be vaccinated
against seasonal influenza weighs perception of individual risk of
disease against the direct costs of the vaccination, the indirect
costs of the time necessary to be vaccinated (lost opportunity),
and any concerns about adverse vaccination effects [1]. The impli-
cations of individual vaccination in contributing to population
immunity further complicates the decision. Importantly, percep-
tions of disease risk are dynamic and may markedly increase as
disease outbreaks are reported closer to the individual [2–4]. How-
ever, by this time much of the potential for inducing populationthe recipient.
Understanding the drivers of vaccination decisions and how
these are influenced by proximity of perceived risk is a significant
gap in vaccine knowledge relevant to increasing vaccination and
decreasing the burden of infectious disease. We chose to address
this knowledge gap by estimating pastoralist adoption of a live-
stock vaccination against foot-and-mouth disease (FMD). Similar
to seasonal influenza, FMD is episodic and not precisely predictable
in either spatial or temporal spread or in its severity [5], thus cre-
ating uncertainty of disease risk. Furthermore, there are multiple
FMD virus serotypes with each serotype characterized by evolving
strains. FMD vaccines vary in their effectiveness depending on the
‘‘match” between the vaccine and the circulating serotype and
strain [6,7], require repeated immunization to achieve optimal pro-
tection, and are similar to seasonal influenza vaccines in having
effects at both the individual and population levels [8–10]. Unlike
human vaccination or vaccination for zoonotic livestock diseases
that have human health implications, the decision to vaccinate
for FMD solely fixates on livestock health, and thus focuses our
5078 A.F. Railey et al. / Vaccine 36 (2018) 5077–5083analysis on externally influenced, dynamic risk perceptions [11].
Importantly, in households that are characterized by high depen-
dence on livestock, vaccination decisions have broad impacts on
household income and wealth, food security, and expenditures
on human health and education [12]. For FMD specifically, reduc-
tions in milk production, lost animal draught power, and closure
of livestock markets threaten household income and nutritional
security [13].
We surveyed 432 pastoralist households in northern Tanzania
to identify determinants of FMD vaccination decisions relative to
temporal and spatial risk based on two immunization strategies.
We extended a commonly accepted survey method for inferring
preferences, willingness to pay (WTP), to elicit decision responses
for two hypothetical vaccination scenarios. The first is ‘‘routine”
vaccination in which households would vaccinate cattle biannu-
ally, a proactive and planned approach that would support immu-
nity at population scale. The second is ‘‘emergency” vaccination in
which households would vaccinate in the face of a current nearby
outbreak, a situation that presents heightened, individualized risk
introduced by spatial proximity and temporal immediacy. In each
scenario, the stated efficacy of the vaccine was also varied to reflect
the uncertainty of the vaccine matching process and to assess sen-
sitivity to improvements in vaccine risk reduction. Herein we pre-
sent the results of the study and discuss the findings in the context
of identifying approaches to influence household vaccine uptake
and subsequent improved disease control.
2. Materials and methods
2.1. Household survey and data
The survey questionnaire that was used for data collection tar-
geted key decision makers in cattle owning households to identify
behavioral responses and to increase accuracy and precision ofFig. 1. Location of the 10 study sites (triangles) within the Serengeti and Ngorongothose responses. The cross-sectional survey was conducted in April
through July 2016 in the Serengeti and Ngorongoro districts of
northern Tanzania (Fig. 1) and contained questions designed to
capture household characteristics hypothesized to influence vacci-
nationWTP, including household demographics, livestock manage-
ment practices, and knowledge of and history with FMD. Within
the two districts, a two-stage sampling procedure randomly
selected first clusters, then households with the Serengeti district
more intensively sampled for analysis purposes (Supplementary
material) [14]. Design and piloting of the survey instrument fol-
lowed standard statistical practices [14]. Informed consent was
obtained after the nature and possible consequences of the study
had been explained by local enumerators who were trained and
monitored throughout the collection process.
Households in both study districts engage in livestock and agri-
cultural activities for subsistence and income, with some addition-
ally earning income from off-farm activities (Table 1). Households
practice open grazing and own 20 cows compared to the national
average of 4 cows [15], in addition to owning sheep, goats, and
poultry. Consistent with previous estimates of FMD occurrence in
these areas, 69% of the households reported infection within the
past year [16] and expected reductions in milk production during
outbreaks. All households recognized the clinical signs of FMD,
but of the 19% who had vaccinated for any livestock disease in
the past year, none reported vaccinating for FMD. This reflects
the situation of FMD in East Africa as characterized by poor surveil-
lance systems and limited availability of FMD vaccines (Supple-
mentary material).
2.2. Double bounded dichotomous choice contingent valuation
The absence of FMD vaccines in Tanzania during the time of the
study led to the use of the stated preference methodology to infer
the value households place on vaccination. We used the doublero districts in relation to major Tanzanian cities (circles) and parks (dark grey).
Table 1
Descriptive statistics for variables used in analysis.
Variable Mean or proportion Std. Dev. Median Min Max
No formal education 0.16 0.36 0 0 1.0
Income
Monthly off-farm (25,000 Tsh) 0.74 0.46 1.0 0 1.0
Monthly off-farm (25–100,000) 0.13 0.34 0 0 1.0
Monthly off-farm (>100,000) 0.13 0.33 0 0 1.0
Seasonal crops (100,000 Tsh) 0.67 0.47 1.0 0 1.0
Seasonal crops (100–500,000) 0.16 0.36 0 0 1.0
Seasonal crops (>500,000) 0.18 0.38 0 0 1.0
Herd size 42 59 20.0 1.0 530
Expected milk loss (in liters per cow) 0.70 0.59 0.61 0 5.0
Cattle sold in the past year 5.9 6.7 2.0 0 21
FMD experienced in past year 0.69 0.46 1.0 0 1.0
Vaccinated for any cattle disease in past year 0.19 0.40 0 0 1.0
Use government vet 0.34 0.48 0 0 1.0
Vaccine efficacy of 50% 0.45 0.49 0 0 1.0
Male head of household 0.84 0.36 1.0 0 1.0
50% efficacy*male head of household 0.60 0.49 0 0 1.0
Serengeti district 0.59 0.49 1.0 0 1.0
Outbreak @ Neighbor 0.57 0.50 1.0 0 1.0
n = 432
 mean of continuous variables.
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[17,18], which is a standard survey approach that can jointly ana-
lyze willingness to pay to adopt a product and determine factors
underlying adoption behavior. For both the routine and emergency
vaccination strategies, households received an initial, binary choice
(‘yes/no’) question eliciting WTP for a single vaccine dose if it pro-
tects one cow from FMD over a 6-month period. Households then
received a follow up, second binary choice question raising or low-
ering the offered price depending on the response to the first. Each
respondent received the same initial bid price, 2000 Tsh (USD 0.95)
for the routine vaccine and 4000 Tsh (USD 1.90) for the emergency
vaccine, with the follow up bids for the routine vaccines ranging
between 500 Tsh (USD 0.24) and 3500 Tsh (USD 1.67), and the
emergency between 500 (USD 0.24) and 7500 Tsh (USD 3.57).
The binary choice question format of this model is cognitively
easier than other question designs by removing the burden on
the respondent to formulate a price or choose between multiple
hypothetical scenarios [19]. Bias can exist with the double
bounded model if the household’s WTP value changes between
responding to the first bid and the second, follow up bid question
[20]. Use of the interval data model can remove some of this con-
cern by providing robust WTP estimates [21]. Additional pretesting
of bid levels and referencing related vaccine prices reduces large
deviations from the potential market price range [22]. Compared
to the single bounded model that only asks one binary choice ques-
tion, the gain in asymptotic efficiency of the double bounded
approach outweighs the potential bias from anchoring on the ini-
tial bid [23].
2.3. Empirical model
The empirical strategy is modeled according to expected utility
theory and estimated using the maximum likelihood estimator
(Supplementary material). The average emergency WTP is antici-
pated to be higher than the routine WTP by an amount propor-
tional to the change in risk reduction between the two [17,18]. In
an emergency situation, the immediacy of the risk increases the
individual perceived value of vaccination, whereas the delayed
reward of routine vaccination reduces its relative value [24]. How-
ever, households can reasonably plan for biannual vaccination
costs whereas the unanticipated income shock in an emergency,
coupled with increased susceptibility, introduces uncertainty
towards the relative gain from vaccination [25]. We presentedthe routine question first to provide a baseline perception of risk,
followed by the question regarding emergency vaccination.
To reflect the complexity of the vaccine matching process and
assess sensitivity to improvements in vaccine-induced risk reduc-
tion, households were randomly assigned a stated vaccine efficacy
of 50% or 100%. The emergency vaccination question was then con-
ditioned on outbreak distance, either with a neighbor (1 km radius)
or at the village level (5 km radius). The proximity of neighbors
within one kilometer for all households in the study is assumed
to imply immediate, unavoidable exposure. An outbreak at the vil-
lage level attempts to alleviate perceptions of disease risk through
the possibility that exposure has not occurred. The 5 km radius
roughly follows village boundaries and was provided to the
respondent when the household had difficulty conceptualizing vil-
lage proximity.
3. Results
3.1. Routine versus emergency vaccination
Following theoretical and practical guidance on perceived risk
under routine and emergency vaccination scenarios, we expected
differential behavioral processes between the two. To assess the
appropriateness of modeling the two strategies separately, we per-
formed a likelihood ratio test. The test rejected the estimation of
both vaccination strategies jointly in favor of separate models
(Supplementary material), supporting the concept that different
decision-making processes influence each type of vaccination. Esti-
mation of the two models separately then revealed a higher mean
WTP and more variation in the distribution for emergency vaccina-
tion relative to routine, further providing fundamental empirical
evidence that household behavior is differentiated between rou-
tine and emergency strategies (Fig. 2). The mean WTP of emer-
gency vaccination was around 5400 Tsh (95% CI: 3551, 7271 Tsh;
USD 1.69, 3.46) and about 3900 Tsh for a routine strategy (95%
CI: 2555, 5217 Tsh; USD 1.22, 2.48).
3.2. Perceived risk sensitivity
Separate WTP distributions for the two strategies in and of
themselves are not sufficient to conclude that households accu-
rately valued the varying levels of uncertainty and risk associated
with FMD vaccination. To support this conclusion, we would




























Predicted WTP in Tanzanian Shillings
Routine (1590-6716 Tsh)
Emergency (2256-10254 Tsh)
Fig. 2. Distribution of Willingness to Pay Values.
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changes in risk. We therefore first examined the effect of an
increase in vaccine bid price on the probability of adopting vacci-
nation. We found that as the bid price increased for both strategies,
the probability of vaccine acceptance decreased (Table 2), consis-
tent with theoretical expectations [19]. We next compared the
average WTP values for each strategy with the calculated change
in perceived risk reduction between routine and emergency vacci-
nation (Supplementary material). Also following theoretical expec-
tations [17,18], we found the marginal change in risk reduction
going from a routine to an emergency strategy to be of comparable
magnitude to the change in WTP values, with the risk reduction
from an emergency strategy to be higher than a routine strategy.
For perceptions of risk from increased susceptibility, we found
an outbreak with a neighbor compared to an outbreak at the vil-
lage level presented no difference in the value of vaccination. Alter-
ing the vaccine efficacy level by itself did not influence vaccine
valuation for either strategy. Contrary to expectations, households
that received a vaccine of 50% stated efficacy did not value vaccina-
tion differently than those provided with a vaccine of 100% stated
efficacy. However, interacting efficacy level (50 or 100%) with the
head of household gender revealed that a male head of household
that received the vaccine of 50% efficacy would pay less than a
female head of households for either efficacy level and less than
a male head of household receiving a vaccine of 100% efficacy
(routine -1458 Tsh; USD 0.69; emergency 2718 Tsh; USD 1.29).Table 2









500 94 500 89
1000 82 2000 81
1500 58 3500 69
2000 48 4000 65
2500 38 4500 60
3000 29 5000 55
3500 5 7500 30
USD 1.00 = 2100 Tanzanian shillings.3.3. Vaccination determinants
As expected, the drivers behind routine and emergency vaccina-
tion adoption also differed (Table 3). For any health expenditure
decision, diversity and liquidity of household income portfolios
affects household capacity to invest in proactive measures, exem-
plified by routine vaccination, and adjust to near term threats
and shocks, represented by emergency vaccination and the risk
of major disease outbreaks and loss [26]. Our results show income
apart from livestock is a primary determinant of emergency vacci-
nation, while additionally influencing routine adoption but at a
lower magnitude. Compared to households with no off-farm
income, households with higher levels of off-farm income reported
higher valuation of routine (1022 Tsh; USD 0.49) and emergency
vaccinations (1962 and 1763 Tsh; USD 0/93/0.84). Diversity of
income had varying effects on willingness to pay for both strate-
gies. Compared to households with no crop income the prior sea-
son, earning some seasonal crop income (100 to 500,000 Tsh;
USD 47.61–238.10) increased both routine (1635 Tsh; USD 0.78)
and emergency WTP (2294 Tsh; USD 1.09). Being in the highest
income bracket from crop sales in the prior season (>500,000
Tsh; USD 238.10) had no effect on adoption for either vaccine
strategy.
Beyond income, we assessed the role of exogenously deter-
mined motivations to vaccinate by including variables on whether
a household receives livestock health information from a govern-
ment veterinarian and the level of formal education of the head
of household [27]. We found that households citing the govern-
ment veterinarian as their main source of information (35% of
households) reported lower WTP values than those relying on
other sources (663 Tsh; USD 0.32), with augmented effects for
the emergency vaccine (1817 Tsh; USD 0.86). Similarly, results
on the education variable offered corresponding evidence that
households maintain negative perceptions towards vaccination.
We would expect formal education to be associated with adoption
of disease prevention practices. Instead we found no effect of edu-
cation on emergency vaccination, and, for a routine vaccination,
head of households with no formal education (15% of households)
reported higher WTP values than those with formal education
Table 3
Vaccination determinants.
Variable Routine marginal effects (CI 95%) P value Emergency marginal effects (CI 95%) P value
Education (0 = Formal; 1 = No Formal) 681 (7, 1356) 0.096 655 (369, 1679) 0.295
Income
Off-Farm (25,000 Tsh) Base case
Off-Farm (25–100,000) 589 (34, 1213) 0.119 1962 (835, 3090) 0.004
Off-Farm (>100,000) 1022 (360, 1685) 0.010 1763 (672, 2854) 0.007
Crops (100,000 Tsh) Base case
Crops (100–500,000) 1635 (806, 2465) 0.001 2294 (1034, 3554) 0.003
Crops (>500,000) 445 (1067, 176) 0.237 403 (1513, 3554) 0.552
Herd Sizea 26 (192, 243) 0.846 42 (348, 432) 0.859
Expected Milk Loss (in liters per cow) 306 (94, 707) 0.207 423 (205, 1051) 0.270
Cattle sold in past year 36 (0.33, 71) 0.096 11 (48, 71) 0.753
FMD experience in past year (0 = No; 1 = Yes) 241 (751, 270) 0.439 283 (1156, 590) 0.595
Vaccinated for any cattle disease in past year (0 = No; 1 = Yes) 247 (795, 299) 0.457 216 (754, 1186) 0.715
Use of government vet (0 = No; 1 = Yes) 663 (1113, 214) 0.014 1817 (2626, 1008) 0.001
Vaccine efficacy (0 = 100%; 1 = 50%) 1573 (370, 2778) 0.031 2318 (107, 4529) 0.085
Gender (0 = Female; 1 = Male) 1031 (321, 1740) 0.016 857 (478, 2192) 0.292
Gender*efficacy (0 = 100%; 1 = 50%) 1458 (2740, 174) 0.060 2737 (5066, 406) 0.053
District (0 = Ngorongoro; 1 = Serengeti) 270 (751, 212) 0.358 94 (779, 967) 0.860
Outbreak (0 = Village; 1=@Neighbor) 476 (1244, 293) 0.314
Log Likelihood 415 498
Chi-2 Statistic 39.09 41.87
USD 1.00 = 2100 Tanzanian shillings.
a Log of variable.
A.F. Railey et al. / Vaccine 36 (2018) 5077–5083 5081(681 Tsh; USD 0.32). Use of government veterinarians and educa-
tional attainment were uncorrelated across income levels and
villages.
4. Discussion
In agreement with the human health literature, individual risk
perceptions affect the valuation of vaccination [28,29]. Households
place a higher value on vaccines when the threat of disease is per-
ceived as immediate. However, concerns about vaccine efficacy
and the vaccination process also factor into decisions to vaccinate
with an augmented effect in an emergency situation. Unlike
human vaccination or vaccination for zoonotic diseases, FMD vac-
cination minimizes perception of adverse side effects for the vacci-
nated individual but retains the impact on household welfare in
terms of expenditures, loss of income risk, and coping with
resource constraints. This is supported by three main findings in
our study: (i) income is a major determinant in valuing both rou-
tine and emergency vaccination decisions; (ii) diversity of income
promotes vaccination uptake (at least to a point); and (iii) there is a
constant increased willingness to pay for emergency over routine
vaccination. The fact that complete dependence on livestock
income does not consistently promote vaccination further suggests
income liquidity and diversity are important to facilitate risk
responsiveness [30].
Compared to routine vaccination, weighing an unexpected
shock with perceptions of susceptibility and disease severity
increases decision uncertainty for emergency vaccination, as
reflected by the greater variation in WTP. Similar to human sea-
sonal influenza vaccination, imprecise spatial and temporal risk
and disease severity are compounded in an emergency situation
and confounds perceptions on the overall gain from vaccination
relative to disease impact. As with most vaccines, FMD vaccination
requires 7 to 14 days to provide protective immunity [31]. House-
holds do not need to know the precise temporal or spatial informa-
tion required to induce protection to understand that dense
contact networks [32] and the difficulty of self-imposing move-
ment restrictions [33] in pastoralist communities makes the likeli-
hood of near immediate exposure almost certain if an outbreak is
nearby. To support this point, we found no variation in the value
of vaccination between offering an emergency vaccine when anoutbreak is with a neighbor (1 km radius) or at the village level
(5 km radius). Subsequently, for an emergency vaccine, the per-
ceived risk is consistently higher, and the wider variation in WTP
values reflects greater uncertainty about perceived gains from
vaccination.
In both vaccination scenarios, uncertainty about the effective-
ness of vaccination in preventing disease underlies the decision
process. This includes doubts about vaccine effectiveness that are
common to both human and animal vaccines. Governmental and
non-governmental professional institutions attempt to alleviate
concerns about effectiveness relative to cost and risk, but similar
to influenza, these professional sources often struggle to fully over-
come individual or community uncertainty. Pastoralist’s inexperi-
ence with FMD vaccines generally and with appropriately strain
matched vaccines specifically could contribute to uncertainty in
the value of vaccination, even though FMD is a common, episodic
disease familiar to the community. This resembles concerns for
seasonal influenza about the match of the vaccine strain to the cir-
culating strain [34,35]. Gender-based differences in WTP may
reveal this, whereas men have more experience than women with
non-poultry livestock vaccination and appropriately demonstrate
sensitivity to improvements in vaccine quality. Furthermore, the
disconnection between educational attainment and a positive deci-
sion for vaccination, may explain this, as informed households
would rationally be less likely to adopt what are perceived as inef-
fective vaccines. These differences may also reflect overall lack of
experience with vaccines. In the few households that had vacci-
nated for any livestock disease in the past year there was no influ-
ence on WTP for either FMD vaccination strategy. Lack of positive
experience coupled with a poor understanding about the value of
population level immunity—a concern shared with adoption of
human vaccines, including seasonal influenza—indicates the rela-
tive benefits of vaccination remain imprecise.
For any vaccination strategy, we emphasize the need for clear
messages about the public and private benefits of vaccination.
Households seem to apprehend the presence or absence of direct
FMD risk and accurately valued vaccination relative to risk. How-
ever, similar to other animal vaccination WTP studies, this rela-
tionship between perceived disease risk and WTP for effective
vaccines [36] coupled with inadequate understanding of vaccines
and population level effects [37,38] suggests households need
5082 A.F. Railey et al. / Vaccine 36 (2018) 5077–5083additional information and assurance that the benefits of the cho-
sen vaccination strategy exceed the costs. Clearly communicating
the need to vaccinate early, prior to local outbreaks, along with
presenting an effective and serotype specific vaccine priced to
capture the most economically vulnerable populations will help
decrease the perceived risk of vaccination. In light of the limited
positive influence on adoption from professionals, consistent
with prior human and animal vaccination studies [12,39–41],
dissemination of vaccine knowledge through informal social
networks is critical in overcoming existing negative expectations.
Improved surveillance to detect circulating FMD serotypes and
strains and vaccines that are better matched to local strains
should reduce household vaccination uncertainty and increase
vaccine uptake.
Our research is limited to eliciting stated preferences for vac-
cines that may differ from actual market outcomes and activities.
Additional investigation into vaccine attributes may provide more
precise estimates on specific vaccine qualities and delivery
options that will further enhance uptake. Specifying outbreak dis-
tance with respect to context-specific herd contact distances may
also increase our knowledge on thresholds to risk perceptions.
Finally, access to panel data or responses directly before, during,
and after FMD outbreaks would improve documentation of how
perceptions of risk change with respect to real-time temporal
immediacy.
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